585 related articles for article (PubMed ID: 14728051)
1. Current management of acute symptomatic deep vein thrombosis.
Heit JA
Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051
[TBL] [Abstract][Full Text] [Related]
2. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation in Patients With Cirrhosis: Caught Between a Rock-Liver and a Hard Place.
Ha NB; Regal RE
Ann Pharmacother; 2016 May; 50(5):402-9. PubMed ID: 26861989
[TBL] [Abstract][Full Text] [Related]
4. Outpatient management of anticoagulation therapy.
du Breuil AL; Umland EM
Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
[TBL] [Abstract][Full Text] [Related]
5. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
6. Early discharge of patients with venous thromboembolism: implications regarding therapy.
Stein PD; Hull RD; Matta F; Yaekoub AY
Clin Appl Thromb Hemost; 2010 Apr; 16(2):141-5. PubMed ID: 19833629
[TBL] [Abstract][Full Text] [Related]
7. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
[TBL] [Abstract][Full Text] [Related]
8. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
Willey VJ; Bullano MF; Hauch O; Reynolds M; Wygant G; Hoffman L; Mayzell G; Spyropoulos AC
Clin Ther; 2004 Jul; 26(7):1149-59. PubMed ID: 15336480
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
10. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
11. Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy.
Wilbur J; Shian B
Am Fam Physician; 2017 Mar; 95(5):295-302. PubMed ID: 28290648
[TBL] [Abstract][Full Text] [Related]
12. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
Hyers TM; Spyropoulos AC;
J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
[TBL] [Abstract][Full Text] [Related]
13. Treatment of DVT: how long is enough and how do you predict recurrence.
Agnelli G; Becattini C
J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
Jørgensen M; Broholm R; Bækgaard N
Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
[TBL] [Abstract][Full Text] [Related]
15. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
Sun P; Dong DN
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ
Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272
[TBL] [Abstract][Full Text] [Related]
19. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of recurrence of thromboembolic disease: maintenance of anticoagulant therapy].
Enrico JF
Ther Umsch; 1989 Oct; 46(10):732-8. PubMed ID: 2814910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
